Variant report
Variant | esv3390192 |
---|---|
Chromosome Location | chr5:1866730-1867808 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:12)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:12 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:1859280..1863274-chr5:1864834..1867333,4 | K562 | blood: | |
2 | chr5:1799200..1802760-chr5:1865091..1870537,7 | MCF-7 | breast: | |
3 | chr5:1831073..1835336-chr5:1866302..1869597,4 | MCF-7 | breast: | |
4 | chr5:1768482..1770789-chr5:1865352..1867896,2 | MCF-7 | breast: | |
5 | chr5:1824315..1827809-chr5:1864869..1867236,3 | MCF-7 | breast: | |
6 | chr5:1864379..1866882-chr5:1868462..1869991,2 | MCF-7 | breast: | |
7 | chr5:1867399..1868193-chr5:1883268..1884191,2 | MCF-7 | breast: | |
8 | chr5:1839864..1842006-chr5:1865990..1868599,2 | MCF-7 | breast: | |
9 | chr5:1796320..1803050-chr5:1863900..1869410,15 | MCF-7 | breast: | |
10 | chr5:1863691..1867065-chr5:1867845..1871510,7 | MCF-7 | breast: | |
11 | chr5:1861297..1869696-chr5:1879554..1886808,27 | MCF-7 | breast: | |
12 | chr5:1851595..1853434-chr5:1866087..1867656,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000171421 | chromatin interactions |
ENSG00000113430 | chromatin interactions |
ENSG00000145494 | chromatin interactions |
ENSG00000249116 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549536878 | chr5:1866741-1866742 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
2 | rs190620137 | chr5:1866755-1866756 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
3 | rs532675803 | chr5:1866757-1866758 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
4 | rs536590450 | chr5:1866809-1866810 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
5 | rs565979252 | chr5:1866820-1866821 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
6 | rs138032897 | chr5:1866839-1866840 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
7 | rs555079033 | chr5:1866848-1866849 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
8 | rs62335769 | chr5:1866858-1866859 | Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs537521021 | chr5:1866875-1866876 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
10 | rs558680946 | chr5:1866884-1866885 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
11 | rs62335770 | chr5:1866893-1866894 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
12 | rs70957397 | chr5:1866914-1866915 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
13 | rs577267368 | chr5:1866918-1866919 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs545360199 | chr5:1866945-1866946 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs555791508 | chr5:1866965-1866966 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs75701612 | chr5:1866968-1866969 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs35576499 | chr5:1866969-1866970 | Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs112586587 | chr5:1866979-1866980 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs368941194 | chr5:1866984-1866985 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
20 | rs182839727 | chr5:1866988-1866989 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
21 | rs543465682 | chr5:1867014-1867015 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
22 | rs569169422 | chr5:1867077-1867078 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
23 | rs536734549 | chr5:1867086-1867087 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
24 | rs531979567 | chr5:1867108-1867109 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
25 | rs187078585 | chr5:1867154-1867155 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
26 | rs115168947 | chr5:1867158-1867159 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
27 | rs4975749 | chr5:1867168-1867169 | Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs528396306 | chr5:1867196-1867197 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
29 | rs548519181 | chr5:1867250-1867251 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
30 | rs570182861 | chr5:1867252-1867253 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
31 | rs537156012 | chr5:1867333-1867334 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
32 | rs73026195 | chr5:1867360-1867361 | Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs372271430 | chr5:1867368-1867369 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
34 | rs13178204 | chr5:1867376-1867377 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
35 | rs200741676 | chr5:1867378-1867379 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
36 | rs60412343 | chr5:1867416-1867417 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
37 | rs377025384 | chr5:1867424-1867425 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
38 | rs370701390 | chr5:1867439-1867440 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
39 | rs370641818 | chr5:1867446-1867447 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
40 | rs111456351 | chr5:1867464-1867465 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
41 | rs112110083 | chr5:1867468-1867469 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
42 | rs200550345 | chr5:1867525-1867526 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
43 | rs112522939 | chr5:1867527-1867528 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
44 | rs112644812 | chr5:1867531-1867532 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
45 | rs554477804 | chr5:1867554-1867555 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
46 | rs62335772 | chr5:1867566-1867567 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
47 | rs375940829 | chr5:1867573-1867574 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
48 | rs576177892 | chr5:1867582-1867583 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
49 | rs543200755 | chr5:1867584-1867585 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
50 | rs577032369 | chr5:1867593-1867594 | Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer ZNF genes & repeats | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16608533 | CNVD |
Cervical cancer | 16585170 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 17925434 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 19181860 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Developmental delay | 19490664 | CNVD |
Human papillomavirus | 17975027 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Gastric cancer | 16891809 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Emphysema | 19352772 | CNVD |
Chordoma | 18071362 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
Oral cancer | 22144094 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:1854000-1872800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr5:1856000-1875400 | Weak transcription | Right Atrium | heart |
3 | chr5:1866000-1868400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr5:1867400-1867600 | Flanking Bivalent TSS/Enh | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr5:1867400-1867600 | Bivalent Enhancer | Esophagus | oesophagus |
6 | chr5:1867400-1867600 | Bivalent Enhancer | Fetal Kidney | kidney |
7 | chr5:1867400-1867600 | Flanking Bivalent TSS/Enh | Gastric | stomach |
8 | chr5:1867400-1867600 | Flanking Bivalent TSS/Enh | Pancreas | Pancrea |
9 | chr5:1867400-1867600 | ZNF genes & repeats | Spleen | Spleen |
10 | chr5:1867600-1868000 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
11 | chr5:1867600-1868400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
12 | chr5:1867600-1870000 | Weak transcription | Pancreas | Pancrea |
13 | chr5:1867800-1868000 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |